Progress has been made in implementing the new corporate strategy and Deinove expects commercial revenues from FY18. Cash resources are sufficient to finance the business for the rest of FY17 and into FY18. Upside for the shares will be dependent on Deinove’s ability to demonstrate commercial deployment of its technology and generate revenue in its target markets.

Continue reading

This version is programmatically created by Responsive Labs and qualified in its entirety to the original PDF.

Powered by Responsive Labs